lomustine and vindesine

lomustine has been researched along with vindesine in 56 studies

Research

Studies (56)

Timeframe	Studies, this research(%)	All Research%
pre-1990	27 (48.21)	18.7374
1990's	17 (30.36)	18.2507
2000's	7 (12.50)	29.6817
2010's	5 (8.93)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doherty, VR; MacKie, RM; Stables, GI	1
Dölken, G; Fuchs, R; Gerhartz, H; Hagen-Aukamp, U; Hiller, E; Löffler, M; Petsch, S; Pflüger, KH; Pfreundschuh, M; Rühl, U	2
Arriagada, R; Baldeyrou, P; de Cremoux, H; Le Chevalier, T; Martin, M; Nasr, E; Pellae-Cosset, B; Ruffie, P; Tarayre, M	1
Arriagada, R; de Cremoux, H; Douillard, JY; Laplanche, A; Le Chevalier, T; Pignon, JP; Quoix, E; Ruffie, P; Tarayre, M	1
Bliss, JM; Gore, ME; Lakhani, S; McElwain, TJ; Perren, TJ; Selby, P	1
Matthay, RA; Twohig, KJ	1
Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, JJ; Merke, DP; Myers, J; Straus, DJ; Yahalom, J	1
Glover, DJ	1
Arriagada, R; Douillard, JY; Lacombe-Terrier, MJ; Laplanche, A; Le Chevalier, T; Martin, M; Quoix, E; Ruffie, P; Tarayre, M	2
Diehl, V; Georgii, A; Gerhartz, H; Hiller, E; Löffler, M; Pfreundschuh, M; Rühl, U; Smith, K	1
Koziner, B; Zori Comba, A	1
Dombrowski, H; Drings, P; Hans, K; Harms, V; Havemann, K; Holle, R; Victor, N; Wolf, M	1
Diehl, V; Fuchs, R; Loeffler, M; Pflüger, KH; Pfreundschuh, MG; Schoppe, WD	1
Straus, DJ	1
Cartei, G; Ceschia, T; Clocchiatti, L; Fasola, G; Galletti, D; Marsilio, P; Morandini, G; Sibau, A	1
Caravelli, J; Chapman, D; Clarkson, BD; Gaynor, J; Lee, BJ; Merke, D; Myers, J; Nisce, LZ; Straus, DJ	1
English, JS; Lever, RS; MacKie, RM; Young, DW	1
Callís, M; Domingo Albós, A; Fernández-Sevilla, A; Juliá, A; Petit, J; Puig, J; Vilá, J; Zuazu, J	1
Badsberg, JH; Hansen, HH; Sørensen, JB	1
Arriagada, R; Baldeyrou, P; Le Chevalier, T; Ruffié, P; Thomas, F	1
Tanneberger, S	1
Drings, P; Gropp, C; Hans, K; Havemann, K; Heim, M; Holle, R; Manke, HG; Schroeder, M; Victor, N; Wolf, M	1
Drings, P; Gropp, C; Hans, K; Havemann, K; Heim, M; Holle, R; Klapsing, J; Manke, HG; Schroeder, M; Viktor, N	1
Aabo, K; Bork, E; Bødker, B; Dombernowsky, P; Hansen, HH; Hansen, M; Malmberg, R; Sørensen, JB	1
Antman, KH; Ryan, LM; Siegel, RD	1
Carmo-Pereira, J; Costa, FO; Henriques, E	1
Bajetta, E; Bonadonna, G; Buzzoni, R; Nava, M; Vaglini, M; Viviani, S	1
Arriagada, R; Baldeyrou, P; Duroux, P; Le Chevalier, T; Martin, M; Rouesse, J; Ruffié, P; Tarayre, M	1
Arriagada, R; Baldeyrou, P; Duroux, P; Jacquotte, A; Le Chevalier, T; Martin, M; Rouesse, J; Sancho-Garnier, H	1
Caille, P; Elias, D; Kac, J; Lasser, P; Le Chevalier, T; Rouesse, J; Rougier, P; Spielmann, M; Zummer, K	1
Drings, P; Gropp, C; Havemann, K; Konrad, RM; Liesenfeld, A; Mahnke, HG; Seifert, W; Thomas, C; Wellens, W; Westerhausen, M	1
Clarkson, BD; Koziner, B; Lee, BJ; Myers, J; Straus, DJ	1
Arlin, Z; Gee, T; Kempin, S; Koziner, B; Lee, BJ; McCormick, B; Mertelsmann, R; Myers, J; Nisce, LZ; Straus, DJ	1
Kelsen, D	1
Soukop, M	1
Avanzini, P; Cavanna, L; Di Renzo, N; Federico, M; Gobbi, PG; Grignani, G; Iannitto, E; Narni, F; Partesotti, G; Pieresca, C	1
Badal, MD; Bezanilla, JL; Castel, V; Llombart, A; Melero, C; Mulet, J; Ruiz-Jiménez, JI; Sánchez de Toledo, J	1
Cairncross, JG	1
Gauthier, T; Maurel, P; Placidi, M; Rahmani, R; Zhou, XJ; Zhou-Pan, XR	1
Diehl, V; Geilen, W; Hasenclever, D; Loeffler, M; Nisters-Backes, H; Pfreundschuh, M; Ruehl, U; Sieber, M; Smith, K; Tesch, H	1
Buccheri, G; Ferrigno, D	1
Angrilli, F; Ascari, E; Bertè, R; Broglia, C; Cavanna, L; Di Renzo, N; Ghirardelli, ML; Gobbi, PG; Iannitto, E; Molica, S; Petrilli, MP	1
Bruner, JM; Chang, SM; Choucair, A; Flynn, PJ; Gleason, MJ; Hess, KR; Jaeckle, KA; Kyritsis, AP; Levin, VA; Prados, MD; Uhm, JH	1
Alietti, A; Baldini, L; Colombi, M; Guffanti, A; Latargia, ML; Maiolo, AT; Vener, C	1
Angelucci, E; Baldini, L; Bordonaro, R; Broglia, C; Cavanna, L; Chisesi, T; Deliliers, GL; Federico, M; Gobbi, PG; Levis, A; Liberati, M; Merli, F; Pavone, V; Santini, G; Stelitano, C; Vitolo, U	1
Broglia, C; Cavanna, L; Chisesi, T; Corazza, GR; Corbella, F; Federico, M; Gobbi, PG; Iannitto, E; La Sala, A; Levis, A; Molica, S; Pavone, V; Sacchi, S; Valentino, F	1
Diehl, V; Evens, AM; Hutchings, M	1
Federico, M; Gentile, M; Gobbi, P; Hohaus, S; Iannitto, E; La Sala, A; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Montanini, A; Morabito, F; Scalone, R; Stelitano, C; Voso, MT	1
Baldini, L; Bellei, M; Bordonaro, R; Chisesi, T; Federico, M; Gobbi, P; Levis, A; Liberati, M; Luminari, S; Marcheselli, L; Merli, F; Montanini, A; Pavone, V; Pesce, EA; Stelitano, C; Vitolo, U	1
Angrilli, F; Baldini, L; Cascavilla, N; Federico, M; Ferrari, A; Galimberti, S; Gobbi, PG; Ilariucci, F; Luminari, S; Mammi, C; Marcheselli, L; Merli, F; Musso, M; Polimeno, G; Scalzulli, PR; Stelitano, C	1
Chen, YL; Ma, XH; Qiu, ZY; Ren, CA; Wang, YF; Xu, WJ	1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M	1
Benfenati, E; Raska, I; Toropov, AA; Toropova, AP	1

Reviews

7 review(s) available for lomustine and vindesine

Article	Year
Pulmonary effects of cytotoxic agents other than bleomycin. Clinics in chest medicine, 1990, Volume: 11, Issue:1 Topics: Antineoplastic Agents; Bleomycin; Busulfan; Carmustine; Cyclophosphamide; Humans; Lomustine; Methotrexate; Mitomycins; Pulmonary Fibrosis; Vinblastine; Vindesine	1990
[Rescue treatment in Hodgkin's disease]. Sangre, 1987, Volume: 32, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine	1987
Treatment of advanced Hodgkin's disease. Hematology/oncology clinics of North America, 1989, Volume: 3, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine	1989
Chemotherapy of esophageal cancer. Seminars in oncology, 1984, Volume: 11, Issue:2 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Doxorubicin; Esophageal Neoplasms; Etoposide; Fluorouracil; Humans; Lomustine; Methotrexate; Mitoguazone; Mitomycin; Mitomycins; Neoplasm Metastasis; Postoperative Care; Preoperative Care; Vinblastine; Vindesine	1984
Management of non-small-cell cancer. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1984, Volume: 92 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Drug Evaluation; Humans; Lomustine; Lung Neoplasms; Mechlorethamine; Prognosis; Vinblastine; Vincristine; Vindesine	1984
Aggressive oligodendroglioma: a chemosensitive tumor. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1994, Volume: 135 Topics: Alkylating Agents; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Chemotherapy, Adjuvant; Cisplatin; Clinical Trials, Phase II as Topic; Combined Modality Therapy; Cyclophosphamide; Glioma; Humans; Lomustine; Multicenter Studies as Topic; Neoplasm Recurrence, Local; Oligodendroglioma; Procarbazine; Salvage Therapy; Vincristine; Vindesine	1994
Treatment of Hodgkin lymphoma: the past, present, and future. Nature clinical practice. Oncology, 2008, Volume: 5, Issue:9 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials, Phase III as Topic; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Multicenter Studies as Topic; Neoplasm Staging; Prednisone; Procarbazine; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine	2008

Trials

29 trial(s) available for lomustine and vindesine

Article	Year
[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group]. Medizinische Klinik (Munich, Germany : 1983), 1992, Nov-15, Volume: 87, Issue:11 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Dose-Response Relationship, Drug; Doxorubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine	1992
[Combination of chemotherapy (vindesine, lomustine, cisplatin, cyclophosphamide) and thoracic radiotherapy in nonresectable non-small cell bronchial carcinoma: final results of a phase II clinical trial]. Bulletin du cancer, 1992, Volume: 79, Issue:7 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Radiotherapy Dosage; Survival Analysis; Vindesine	1992
ASTRO (American Society for Therapeutic Radiology and Oncology) plenary: Effect of chemotherapy on locally advanced non-small cell lung carcinoma: a randomized study of 353 patients. GETCB (Groupe d'Etude et Traitement des Cancers Bronchiques), FNCLCC (Fé International journal of radiation oncology, biology, physics, 1991, Volume: 20, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Survival Rate; Vindesine	1991
Prognostic factors among 185 adults with newly diagnosed advanced Hodgkin's disease treated with alternating potentially noncross-resistant chemotherapy and intermediate-dose radiation therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1990, Volume: 8, Issue:7 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Hematocrit; Hodgkin Disease; Humans; Lomustine; Lymphatic Metastasis; Male; Mechlorethamine; Melphalan; Middle Aged; Models, Biological; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Remission Induction; Survival Analysis; Vinblastine; Vincristine; Vindesine	1990
Radiotherapy alone versus combined chemotherapy and radiotherapy in nonresectable non-small-cell lung cancer: first analysis of a randomized trial in 353 patients. Journal of the National Cancer Institute, 1991, Mar-20, Volume: 83, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Female; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Metastasis; Vindesine	1991
[Intermediate results of the German Hodgkin's disease therapy study]. Onkologie, 1986, Volume: 9, Issue:3 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Germany, West; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Prednisone; Procarbazine; Prognosis; Radiotherapy Dosage; Vinblastine; Vincristine; Vindesine	1986
[Therapy studies of the German Hodgkin's Study Group. Intermediate results of the study protocols HD1, HD2, and HD3]. Onkologie, 1987, Volume: 10, Issue:2 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Neoplasm Staging; Pilot Projects; Prednisone; Procarbazine; Prognosis; Vinblastine; Vincristine; Vindesine	1987
The prognostic value of response to the first cycle of chemotherapy in small cell lung cancer. Results of a multicenter German trial. European journal of cancer & clinical oncology, 1987, Volume: 23, Issue:8 Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Small Cell; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Nimustine; Nitrosourea Compounds; Peplomycin; Prognosis; Random Allocation; Vincristine; Vindesine	1987
Treatment of advanced Hodgkin's disease. Hematology/oncology clinics of North America, 1989, Volume: 3, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Leukemia; Lomustine; Lymphoma; Male; Mechlorethamine; Melphalan; Middle Aged; Neoplasms, Multiple Primary; Prednisone; Procarbazine; Remission Induction; Vinblastine; Vincristine; Vindesine	1989
Results and prognostic factors following optimal treatment of advanced Hodgkin's disease. Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 1989, Volume: 117 Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Doxorubicin; Hodgkin Disease; Humans; Lomustine; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Randomized Controlled Trials as Topic; Vinblastine; Vincristine; Vindesine	1989
Alternating versus sequential chemotherapy in small cell lung cancer. A randomized German multicenter trial. Cancer, 1987, Mar-15, Volume: 59, Issue:6 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Prognosis; Vincristine; Vindesine	1987
Two randomized trials for alternating polychemotherapy of small cell lung cancer. Cancer chemotherapy and pharmacology, 1986, Volume: 18 Suppl 2 Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; Doxorubicin; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Random Allocation; Sex Factors; Smoking; Time Factors; Vincristine; Vindesine	1986
Chemotherapy for adenocarcinoma of the lung (WHO III): A randomized study of vindesine versus lomustine, cyclophosphamide, and methotrexate versus all four drugs. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1987, Volume: 5, Issue:8 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Cyclophosphamide; Drug Evaluation; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Peripheral Nervous System Diseases; Random Allocation; Vindesine	1987
Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma--a prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustine. European journal of cancer & clinical oncology, 1986, Volume: 22, Issue:12 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Dacarbazine; Drug Evaluation; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Procarbazine; Prospective Studies; Random Allocation; Skin Neoplasms; Vindesine	1986
Prospective randomized trial in advanced malignant melanoma with cis-platinum, vindesine, and etoposide vs. cis-platinum, vindesine, and lomustine. American journal of clinical oncology, 1985, Volume: 8, Issue:5 Topics: Adult; Alopecia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials as Topic; Etoposide; Female; Humans; Leukopenia; Lomustine; Male; Melanoma; Middle Aged; Nausea; Neoplasm Metastasis; Prospective Studies; Random Allocation; Skin Neoplasms; Thrombocytopenia; Vindesine; Vomiting	1985
Treatment of advanced Hodgkin's disease with chemotherapy and irradiation. Controlled trial of two versus three alternating, potentially non-cross-resistant drug combinations. The American journal of medicine, 1984, Volume: 76, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Clinical Trials as Topic; Combined Modality Therapy; Dacarbazine; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine	1984
Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease. Leukemia & lymphoma, 1994, Volume: 14, Issue:1-2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Life Tables; Lomustine; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisone; Procarbazine; Prognosis; Prospective Studies; Remission Induction; Risk Factors; Salvage Therapy; Survival Analysis; Survival Rate; Treatment Failure; Vinblastine; Vincristine; Vindesine	1994
Treatment of stage III neuroblastoma with emphasis on intensive induction chemotherapy: a report from the Neuroblastoma Group of the Spanish Society of Pediatric Oncology. Medical and pediatric oncology, 1995, Volume: 24, Issue:1 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Female; Humans; Infant; Lomustine; Male; Melphalan; Neuroblastoma; Remission Induction; Treatment Outcome; Vindesine	1995
Radiotherapy alone versus combined chemotherapy and radiotherapy in unresectable non-small cell lung carcinoma. Lung cancer (Amsterdam, Netherlands), 1994, Volume: 10 Suppl 1 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Large Cell; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Life Tables; Lomustine; Lung Neoplasms; Neoplasm Recurrence, Local; Survival Analysis; Treatment Outcome; Vindesine	1994
Further chemotherapy versus low-dose involved-field radiotherapy as consolidation of complete remission after six cycles of alternating chemotherapy in patients with advance Hodgkin's disease. German Hodgkins' Study Group (GHSG). Annals of oncology : official journal of the European Society for Medical Oncology, 1995, Volume: 6, Issue:9 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Prednisone; Procarbazine; Prognosis; Prospective Studies; Radiotherapy Dosage; Remission Induction; Survival Rate; Treatment Failure; Treatment Outcome; Vinblastine; Vincristine; Vindesine	1995
Efficacy of platinum-based regimens in non-small cell lung cancer. A negative report from the Cuneo Lung Cancer Study Group. Lung cancer (Amsterdam, Netherlands), 1997, Volume: 18, Issue:1 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Administration Schedule; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Mitomycin; Quality of Life; Vindesine	1997
Lomustine and melphalan cannot be replaced by cyclophosphamide and etoposide without reducing efficacy in MOPPEBVCAD chemotherapy for advanced Hodgkin's disease. Haematologica, 2000, Volume: 85, Issue:7 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Epirubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Prospective Studies; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2000
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme. Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:10 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Cisplatin; Cyclophosphamide; Disease-Free Survival; Dose-Response Relationship, Drug; Eflornithine; Female; Glioblastoma; Humans; Lomustine; Male; Middle Aged; Procarbazine; Prospective Studies; Time Factors; Vincristine; Vindesine	2000
OPP-EBV-CAD regimen as salvage treatment in advanced refractory or resistant multiple myeloma. Leukemia & lymphoma, 2000, Volume: 40, Issue:1-2 Topics: Adult; Aged; Agranulocytosis; Anemia; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cause of Death; Drug Administration Schedule; Drug Resistance, Neoplasm; Epirubicin; Humans; Lomustine; Melphalan; Middle Aged; Multiple Myeloma; Prednisone; Procarbazine; Salvage Therapy; Survival Rate; Thrombocytopenia; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2000
ABVD versus modified stanford V versus MOPPEBVCAD with optional and limited radiotherapy in intermediate- and advanced-stage Hodgkin's lymphoma: final results of a multicenter randomized trial by the Intergruppo Italiano Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2005, Dec-20, Volume: 23, Issue:36 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Dacarbazine; Disease-Free Survival; Doxorubicin; Etoposide; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2005
MOPPEBVCAD chemotherapy with limited and conditioned radiotherapy in advanced Hodgkin's lymphoma: 10-year results, late toxicity, and second tumors. Clinical cancer research : an official journal of the American Association for Cancer Research, 2006, Jan-15, Volume: 12, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Disease-Free Survival; Doxorubicin; Drug-Related Side Effects and Adverse Reactions; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasms, Second Primary; Pilot Projects; Prednisone; Procarbazine; Survival Rate; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2006
Role of glutathione-S-transferase (GST) polymorphisms in patients with advanced Hodgkin lymphoma: results from the HD2000 GISL trial. Leukemia & lymphoma, 2012, Volume: 53, Issue:3 Topics: Adult; Anemia; Antineoplastic Combined Chemotherapy Protocols; Biotransformation; Bleomycin; Carboplatin; Cyclophosphamide; Dacarbazine; Doxorubicin; Epirubicin; Etoposide; Female; Gene Deletion; Genetic Predisposition to Disease; Genotype; Glutathione S-Transferase pi; Glutathione Transferase; Hodgkin Disease; Humans; Lomustine; Male; Middle Aged; Neoplasm Proteins; Polymorphism, Genetic; Polymorphism, Single Nucleotide; Prednisone; Procarbazine; Prognosis; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2012
Long-term follow-up analysis of HD9601 trial comparing ABVD versus Stanford V versus MOPP/EBV/CAD in patients with newly diagnosed advanced-stage Hodgkin's lymphoma: a study from the Intergruppo Italiano Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2011, Nov-10, Volume: 29, Issue:32 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Doxorubicin; Female; Follow-Up Studies; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Neoplasm Staging; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine	2011
Long-Term Results of the HD2000 Trial Comparing ABVD Versus BEACOPP Versus COPP-EBV-CAD in Untreated Patients With Advanced Hodgkin Lymphoma: A Study by Fondazione Italiana Linfomi. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 2016, Apr-10, Volume: 34, Issue:11 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Disease-Free Survival; Doxorubicin; Drug Administration Schedule; Epirubicin; Etoposide; Female; Follow-Up Studies; Hodgkin Disease; Humans; Incidence; Italy; Kaplan-Meier Estimate; Lomustine; Male; Melphalan; Middle Aged; Neoplasm Staging; Neoplasms, Second Primary; Prednisone; Procarbazine; Treatment Outcome; Vinblastine; Vincristine; Vindesine	2016

Other Studies

21 other study(ies) available for lomustine and vindesine

Article	Year
Nine years' experience of BELD combination chemotherapy (bleomycin, vindesine, CCNU and DTIC) for metastatic melanoma. The British journal of dermatology, 1992, Volume: 127, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Staging; Survival Rate; Vindesine	1992
Chemotherapy for malignant melanoma: combinations and high doses produce more responses without survival benefit. British journal of cancer, 1990, Volume: 61, Issue:2 Topics: Adolescent; Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Dacarbazine; Female; Humans; Lomustine; Male; Melanoma; Melphalan; Middle Aged; Neoplasm Metastasis; Retrospective Studies; Vincristine; Vindesine	1990
New approaches to the chemotherapy of melanoma. Oncology (Williston Park, N.Y.), 1991, Volume: 5, Issue:5 Topics: Alkaloids; Amifostine; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Bone Marrow Transplantation; Carmustine; Cisplatin; Cyclophosphamide; Dacarbazine; Daunorubicin; Humans; Lomustine; Melanoma; Nitrosourea Compounds; Paclitaxel; Procarbazine; Tamoxifen; Taurine; Thiotepa; Vincristine; Vindesine	1991
Lomustine, etoposide, vindesine, and dexamethasone (CEVD) in Hodgkin's lymphoma refractory to cyclophosphamide, vincristine, procarbazine, and prednisone (COPP) and doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD): a multicenter trial of the Ge Cancer treatment reports, 1987, Volume: 71, Issue:12 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cyclophosphamide; Dacarbazine; Dexamethasone; Doxorubicin; Drug Resistance; Etoposide; Hodgkin Disease; Humans; Lomustine; Middle Aged; Multi-Institutional Systems; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine	1987
Effectiveness and toxicity of "BELD" polychemotherapy in advanced malignant melanoma. Tumori, 1989, Jun-30, Volume: 75, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Female; Humans; Lomustine; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Remission Induction; Skin Neoplasms; Vindesine	1989
The use of BELD combination chemotherapy (bleomycin, vindesine, CCNU, and DTIC) in advanced malignant melanoma. Cancer, 1985, May-01, Volume: 55, Issue:9 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Dacarbazine; Drug Administration Schedule; Female; Humans; Lomustine; Male; Melanoma; Middle Aged; Neoplasm Metastasis; Pilot Projects; Skin Neoplasms; Vinblastine; Vindesine	1985
[Vindesine, CCNU, high-dosage ara-C, and prednisolone (VINAP regimen) in the treatment of relapsing or refractory non-Hodgkin's lymphomas]. Sangre, 1989, Volume: 34, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cytarabine; Drug Evaluation; Drug Resistance; Female; Humans; Lomustine; Lymphoma, Non-Hodgkin; Male; Middle Aged; Neoplasm Recurrence, Local; Prednisolone; Remission Induction; Vindesine	1989
Response to cytostatic treatment in inoperable adenocarcinoma of the lung: critical implications. British journal of cancer, 1989, Volume: 60, Issue:3 Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Female; Humans; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Prognosis; Prospective Studies; Vindesine	1989
Should chemotherapy response be evaluated separately in sequential chemotherapy-radiotherapy schedules in locally advanced nonsmall-cell lung carcinoma? Antibiotics and chemotherapy, 1988, Volume: 41 Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Neoplasm Recurrence, Local; Time Factors; Vindesine	1988
[Antineoplastic chemotherapy for bronchial carcinoma]. Archiv fur Geschwulstforschung, 1985, Volume: 55, Issue:1 Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Humans; Lomustine; Lung Neoplasms; Methotrexate; Podophyllotoxin; Procarbazine; Vinblastine; Vincristine; Vindesine	1985
Adults with Ewing's sarcoma. An analysis of 16 patients at the Dana-Farber Cancer Institute. American journal of clinical oncology, 1988, Volume: 11, Issue:6 Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Dactinomycin; Doxorubicin; Female; Humans; Lomustine; Male; Melphalan; Middle Aged; Prednisone; Prognosis; Sarcoma, Ewing; Vincristine; Vindesine	1988
[Inoperable lung epidermoid cancer non metastasizing. A phase II trial using radiotherapy and combined chemotherapy]. Bulletin du cancer, 1985, Volume: 72, Issue:1 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Follow-Up Studies; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine	1985
Combined chemotherapy (vindesine, lomustine, cisplatin, and cyclophosphamide) and radical radiotherapy in inoperable nonmetastatic squamous cell carcinoma of the lung. Cancer treatment reports, 1985, Volume: 69, Issue:5 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Humans; Lomustine; Lung Neoplasms; Male; Middle Aged; Vinblastine; Vindesine	1985
[Combination vindesine, cyclophosphamide, cis-platinum and CCNU in esophageal epidermoid cancer. Preliminary analysis of 64 cases]. Bulletin du cancer, 1985, Volume: 72, Issue:3 Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Drug Evaluation; Esophageal Neoplasms; Female; Humans; Lomustine; Male; Middle Aged; Vindesine	1985
[3 multicenter phase II studies of the treatment of small cell bronchogenic carcinoma (incl. AIO studies BI + BII)]. Onkologie, 1984, Volume: 7, Issue:3 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Bronchogenic; Carcinoma, Small Cell; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Evaluation; Etoposide; Female; Humans; Ifosfamide; Lomustine; Lung Neoplasms; Male; Methotrexate; Middle Aged; Vinblastine; Vincristine; Vindesine	1984
Combination chemotherapy for the treatment of Hodgkin's disease in relapse. Results with lomustine (CCNU), melphalan (Alkeran), and vindesine (DVA) alone (CAD) and in alternation with MOPP and doxorubicin (Adriamycin), bleomycin, and vinblastine (ABV). Cancer chemotherapy and pharmacology, 1983, Volume: 11, Issue:2 Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Doxorubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Melphalan; Middle Aged; Prednisone; Procarbazine; Vinblastine; Vincristine; Vindesine	1983
MOPP/EBV/CAD hybrid chemotherapy with or without limited radiotherapy in advanced or unfavorably presenting Hodgkin's disease: a report from the Italian Lymphoma Study Group. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 1993, Volume: 11, Issue:4 Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Doxorubicin; Drug Administration Schedule; Epirubicin; Female; Hodgkin Disease; Humans; Lomustine; Male; Mechlorethamine; Middle Aged; Prednisone; Procarbazine; Survival Rate; Vinblastine; Vincristine; Vindesine	1993
Human liver microsomal cytochrome P450 3A isozymes mediated vindesine biotransformation. Metabolic drug interactions. Biochemical pharmacology, 1993, Feb-24, Volume: 45, Issue:4 Topics: Adult; Antibodies; Biotransformation; Cytochrome P-450 CYP2E1; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Doxorubicin; Drug Design; Drug Interactions; Female; Humans; Isoenzymes; Kinetics; Lomustine; Male; Microsomes, Liver; Middle Aged; Mixed Function Oxygenases; Teniposide; Vindesine	1993
[Effect of BD Regimen Combined with Cyclophosphamide and Pirarubicin in Treatment of Relapse/Refractory Multiple Myeloma]. Zhongguo shi yan xue ye xue za zhi, 2016, Volume: 24, Issue:5 Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Doxorubicin; Humans; Lomustine; Multiple Myeloma; Neoplasm Recurrence, Local; Vindesine	2016
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors. Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21 Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship	2008
QSPR modeling of octanol/water partition coefficient of antineoplastic agents by balance of correlations. European journal of medicinal chemistry, 2010, Volume: 45, Issue:4 Topics: Antineoplastic Agents; Models, Chemical; Octanols; Quantitative Structure-Activity Relationship; Water	2010